Tag: structural heart devices market trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Structural Heart Devices Market Between 2026 And 2030?

The structural heart devices market has experienced significant growth in recent years. Its value is expected to rise from $11.37 billion in 2025 to $12.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.8%. This historical expansion can be linked to the rising occurrence of structural heart conditions, an increasingly older global population, the rapid adoption of valve replacement technologies, the growth of specialized cardiac centers, and enhancements in interventional cardiology techniques.

The structural heart devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $17.23 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. Key drivers for this growth during the forecast period include a heightened preference for less invasive medical procedures, increased capital directed towards cardiovascular advancements, the broadened scope of pediatric heart interventions, the increasing uptake of artificial intelligence-supported diagnostic tools, and a greater need for implants that are both robust and enduring. Prominent trends expected during the forecast timeframe encompass the wider acceptance of transcatheter heart valve operations, a rising requirement for cardiac implants that are minimally invasive, the expanding incorporation of sophisticated imaging and navigation technologies, the development of catheter-based delivery methods, and a sharpened emphasis on designing devices tailored to individual patients.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Which Drivers Are Supporting The Structural Heart Devices Market Growth?

The increasing occurrence of cardiovascular diseases is anticipated to fuel expansion within the structural heart device market in the future. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart attacks, and strokes. Globally, instances of cardiovascular diseases, covering heart disease and stroke, have consistently grown, attributed to factors like inactive lifestyles, unhealthy eating, increasing obesity, smoking, and an aging demographic. These structural heart devices address cardiovascular diseases by mending or substituting impaired heart valves, rectifying anatomical flaws, and enhancing cardiac performance and patient results. As an illustration, the American Heart Association, a US-based non-profit organization, reported in January 2024 that the age-adjusted mortality rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the escalating incidence of cardiovascular diseases is boosting the expansion of the structural heart device market.

Which Segment Classifications Are Used In The Structural Heart Devices Market Segment Analysis?

The structural heart devices market covered in this report is segmented –

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems

2) By Procedure: Replacement Procedures, Repair Procedures

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications

4) By Age Group: Pediatric, Adults

Subsegments:

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

Which Trends Are Expected To Impact The Structural Heart Devices Market?

Major companies within the structural heart devices market are concentrating on developing innovative solutions, such as next-generation transcatheter heart valves, to enhance durability, minimize complications, and expand minimally invasive treatment options. These next-generation transcatheter heart valves are minimally invasive replacement valves engineered with advanced materials and features like anti-calcification tissue and improved sealing, which collectively boost their durability and diminish complications compared to prior valve iterations. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, launched a next-generation transcatheter heart valve platform in India, offering a long-lasting, minimally invasive treatment for aortic stenosis in patients unsuitable for open-heart surgery. This advanced valve’s key features include calcification-resistant tissue technology to prevent calcium buildup and improve longevity, a taller outer sealing skirt to reduce paravalvular leaks, and dry tissue storage for simpler hospital handling. Additionally, the platform supports a “lifetime management” strategy, enabling minimally invasive valve-in-valve procedures for future interventions and ensuring sustained treatment effectiveness.

Which Firms Are Contributing To The Structural Heart Devices Market Ecosystem?

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH

Get The Full Structural Heart Devices Market Report:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Which Region Is The Top Contributor To The Structural Heart Devices Market By Share?

North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Structural Heart Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Browse Through More Reports Similar to the Global Structural Heart Devices Market 2026, By The Business Research Company

Structural Heart Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Cardiac Mapping Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-mapping-global-market-report

Cardiovascular Ultrasound Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Structural Heart Devices Market Between 2026 And 2030?

The structural heart devices market has experienced significant growth in recent years. Its value is expected to rise from $11.37 billion in 2025 to $12.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.8%. This historical expansion can be linked to the rising occurrence of structural heart conditions, an increasingly older global population, the rapid adoption of valve replacement technologies, the growth of specialized cardiac centers, and enhancements in interventional cardiology techniques.

The structural heart devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $17.23 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. Key drivers for this growth during the forecast period include a heightened preference for less invasive medical procedures, increased capital directed towards cardiovascular advancements, the broadened scope of pediatric heart interventions, the increasing uptake of artificial intelligence-supported diagnostic tools, and a greater need for implants that are both robust and enduring. Prominent trends expected during the forecast timeframe encompass the wider acceptance of transcatheter heart valve operations, a rising requirement for cardiac implants that are minimally invasive, the expanding incorporation of sophisticated imaging and navigation technologies, the development of catheter-based delivery methods, and a sharpened emphasis on designing devices tailored to individual patients.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Which Drivers Are Supporting The Structural Heart Devices Market Growth?

The increasing occurrence of cardiovascular diseases is anticipated to fuel expansion within the structural heart device market in the future. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart attacks, and strokes. Globally, instances of cardiovascular diseases, covering heart disease and stroke, have consistently grown, attributed to factors like inactive lifestyles, unhealthy eating, increasing obesity, smoking, and an aging demographic. These structural heart devices address cardiovascular diseases by mending or substituting impaired heart valves, rectifying anatomical flaws, and enhancing cardiac performance and patient results. As an illustration, the American Heart Association, a US-based non-profit organization, reported in January 2024 that the age-adjusted mortality rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the escalating incidence of cardiovascular diseases is boosting the expansion of the structural heart device market.

Which Segment Classifications Are Used In The Structural Heart Devices Market Segment Analysis?

The structural heart devices market covered in this report is segmented –

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems

2) By Procedure: Replacement Procedures, Repair Procedures

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications

4) By Age Group: Pediatric, Adults

Subsegments:

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

Which Trends Are Expected To Impact The Structural Heart Devices Market?

Major companies within the structural heart devices market are concentrating on developing innovative solutions, such as next-generation transcatheter heart valves, to enhance durability, minimize complications, and expand minimally invasive treatment options. These next-generation transcatheter heart valves are minimally invasive replacement valves engineered with advanced materials and features like anti-calcification tissue and improved sealing, which collectively boost their durability and diminish complications compared to prior valve iterations. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, launched a next-generation transcatheter heart valve platform in India, offering a long-lasting, minimally invasive treatment for aortic stenosis in patients unsuitable for open-heart surgery. This advanced valve’s key features include calcification-resistant tissue technology to prevent calcium buildup and improve longevity, a taller outer sealing skirt to reduce paravalvular leaks, and dry tissue storage for simpler hospital handling. Additionally, the platform supports a “lifetime management” strategy, enabling minimally invasive valve-in-valve procedures for future interventions and ensuring sustained treatment effectiveness.

Which Firms Are Contributing To The Structural Heart Devices Market Ecosystem?

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH

Get The Full Structural Heart Devices Market Report:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Which Region Is The Top Contributor To The Structural Heart Devices Market By Share?

North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Structural Heart Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Browse Through More Reports Similar to the Global Structural Heart Devices Market 2026, By The Business Research Company

Structural Heart Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Cardiac Mapping Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-mapping-global-market-report

Cardiovascular Ultrasound Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Structural Heart Devices Market Between 2026 And 2030?

The structural heart devices market has experienced significant growth in recent years. Its value is expected to rise from $11.37 billion in 2025 to $12.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.8%. This historical expansion can be linked to the rising occurrence of structural heart conditions, an increasingly older global population, the rapid adoption of valve replacement technologies, the growth of specialized cardiac centers, and enhancements in interventional cardiology techniques.

The structural heart devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $17.23 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. Key drivers for this growth during the forecast period include a heightened preference for less invasive medical procedures, increased capital directed towards cardiovascular advancements, the broadened scope of pediatric heart interventions, the increasing uptake of artificial intelligence-supported diagnostic tools, and a greater need for implants that are both robust and enduring. Prominent trends expected during the forecast timeframe encompass the wider acceptance of transcatheter heart valve operations, a rising requirement for cardiac implants that are minimally invasive, the expanding incorporation of sophisticated imaging and navigation technologies, the development of catheter-based delivery methods, and a sharpened emphasis on designing devices tailored to individual patients.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Which Drivers Are Supporting The Structural Heart Devices Market Growth?

The increasing occurrence of cardiovascular diseases is anticipated to fuel expansion within the structural heart device market in the future. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart attacks, and strokes. Globally, instances of cardiovascular diseases, covering heart disease and stroke, have consistently grown, attributed to factors like inactive lifestyles, unhealthy eating, increasing obesity, smoking, and an aging demographic. These structural heart devices address cardiovascular diseases by mending or substituting impaired heart valves, rectifying anatomical flaws, and enhancing cardiac performance and patient results. As an illustration, the American Heart Association, a US-based non-profit organization, reported in January 2024 that the age-adjusted mortality rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the escalating incidence of cardiovascular diseases is boosting the expansion of the structural heart device market.

Which Segment Classifications Are Used In The Structural Heart Devices Market Segment Analysis?

The structural heart devices market covered in this report is segmented –

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems

2) By Procedure: Replacement Procedures, Repair Procedures

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications

4) By Age Group: Pediatric, Adults

Subsegments:

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

Which Trends Are Expected To Impact The Structural Heart Devices Market?

Major companies within the structural heart devices market are concentrating on developing innovative solutions, such as next-generation transcatheter heart valves, to enhance durability, minimize complications, and expand minimally invasive treatment options. These next-generation transcatheter heart valves are minimally invasive replacement valves engineered with advanced materials and features like anti-calcification tissue and improved sealing, which collectively boost their durability and diminish complications compared to prior valve iterations. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, launched a next-generation transcatheter heart valve platform in India, offering a long-lasting, minimally invasive treatment for aortic stenosis in patients unsuitable for open-heart surgery. This advanced valve’s key features include calcification-resistant tissue technology to prevent calcium buildup and improve longevity, a taller outer sealing skirt to reduce paravalvular leaks, and dry tissue storage for simpler hospital handling. Additionally, the platform supports a “lifetime management” strategy, enabling minimally invasive valve-in-valve procedures for future interventions and ensuring sustained treatment effectiveness.

Which Firms Are Contributing To The Structural Heart Devices Market Ecosystem?

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH

Get The Full Structural Heart Devices Market Report:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Which Region Is The Top Contributor To The Structural Heart Devices Market By Share?

North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Structural Heart Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Browse Through More Reports Similar to the Global Structural Heart Devices Market 2026, By The Business Research Company

Structural Heart Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Cardiac Mapping Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-mapping-global-market-report

Cardiovascular Ultrasound Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Structural Heart Devices Market Over The Period 2026–2030?

The structural heart devices market has shown robust expansion in recent years. It is forecast to grow from $11.37 billion in 2025 to $12.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. This historical growth can be linked to the increasing occurrence of structural heart conditions, the global rise in the elderly population, the prompt adoption of valve replacement technologies, the proliferation of cardiac specialty centers, and enhancements in interventional cardiology methods.

The structural heart devices market is projected to experience substantial expansion over the next few years. It is anticipated to grow to $17.23 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.4%. This expansion during the forecast period is primarily driven by a surging preference for minimally invasive procedures, increasing investments in cardiovascular innovation, the broadening of pediatric cardiac interventions, the expanding adoption of AI-assisted diagnostics, and a heightened demand for durable and long-lasting implants. Significant trends expected during this period include the rising adoption of transcatheter heart valve procedures, a growing demand for minimally invasive cardiac implants, the increasing integration of advanced imaging and navigation systems, the expansion of catheter-based delivery technologies, and a stronger focus on patient-specific device design.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp

Which Economic Or Industry Drivers Are Impacting The Structural Heart Devices Market?

The increasing occurrence of cardiovascular conditions is anticipated to boost the expansion of the structural heart device market in the future. Cardiovascular diseases (CVDs) encompass a range of afflictions impacting the heart and its associated blood vessels, including conditions such as coronary artery disease, heart attacks, and strokes. Instances of cardiovascular diseases, specifically heart disease and stroke, have shown a consistent global rise, attributed to inactive lifestyles, unhealthy eating patterns, escalating obesity figures, tobacco use, and an aging demographic. Structural heart devices address cardiovascular ailments by mending or substituting impaired heart valves, rectifying structural flaws, and enhancing cardiac performance and patient prognosis. As an illustration, in January 2024, data from the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted mortality rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, representing a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the growing occurrence of cardiovascular diseases is fueling the expansion of the structural heart device market.

How Is The Structural Heart Devices Market Divided Into Its Major Segments?

The structural heart devices market covered in this report is segmented –

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems

2) By Procedure: Replacement Procedures, Repair Procedures

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications

4) By Age Group: Pediatric, Adults

Subsegments:

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

How Are Trends Transforming The Structural Heart Devices Market Landscape?

Leading companies within the structural heart devices market are concentrating on developing advanced solutions, including innovative next-generation transcatheter heart valves, with the goal of improving durability, decreasing complications, and expanding minimally invasive treatment options. Next-generation transcatheter heart valves are replacement valves that are minimally invasive, featuring advanced materials and attributes like anti-calcification tissue and enhanced sealing, which serve to boost durability and reduce complications when compared to older valves. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, launched a next-generation transcatheter heart valve platform in India, which provides a durable, minimally invasive treatment for aortic stenosis in patients who cannot undergo open-heart surgery. Key attributes of this advanced valve include calcification-resistant tissue technology designed to prevent calcium accumulation and extend longevity, a taller outer sealing skirt to minimize paravalvular leaks, and dry tissue storage to facilitate easier hospital handling. Additionally, the platform supports a “lifetime management” strategy, allowing for minimally invasive valve-in-valve procedures for future interventions and ensuring sustained treatment effectiveness.

Who Are The Prominent Organizations Shaping The Structural Heart Devices Market?

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH

Read the full structural heart devices market report here:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

What Are The Top-Performing Regions Within The Structural Heart Devices Market?

North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Structural Heart Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp

Browse Through More Reports Similar to the Global Structural Heart Devices Market 2026, By The Business Research Company

Structural Heart Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Cardiac Mapping Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-mapping-global-market-report

Cardiovascular Ultrasound Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-ultrasound-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the structural heart devices market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Structural Heart Devices Market By The End Of 2029?

The structural heart devices market has experienced robust expansion over the last few years. Forecasts indicate it will expand from $10.41 billion in 2024 to $11.37 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.3%. Historically, this growth is primarily due to several factors, including a move towards less invasive surgical methods, an increasing need for minimally invasive structural heart devices, continuous training and educational initiatives for medical practitioners, increasing healthcare spending, and a growing patient inclination for non-surgical or minimally invasive treatment choices.

The market for structural heart devices is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $16.1 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. The expansion during the projected period stems from factors such as a rising elderly population, heightened awareness regarding heart health, the introduction of comprehensive screening initiatives, supportive reimbursement policies for structural heart interventions, and prompt regulatory clearances for novel structural heart devices. Key trends anticipated for this forecast timeframe encompass the expanding use of transcatheter valve replacement, continuous innovation in device development utilizing advanced materials, a heightened focus on individualized treatment strategies, the rising prevalence of hybrid procedures, and the incorporation of remote monitoring and telehealth technologies.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp

Which Business Drivers Are Underpinning The Growth Of The Structural Heart Devices Market?

The increasing occurrence of cardiovascular diseases is anticipated to accelerate the expansion of the structural heart device market in the coming years. Cardiovascular diseases (CVDs) are a category of conditions affecting the heart and blood vessels, encompassing ailments such as coronary artery disease, heart attacks, and strokes. The global incidence of cardiovascular diseases, including heart disease and stroke, has been steadily rising, attributed to factors like sedentary lifestyles, inadequate dietary habits, escalating obesity rates, smoking, and an aging population. Structural heart devices serve to treat cardiovascular diseases by repairing or replacing damaged heart valves, correcting structural defects, and improving heart function and overall patient outcomes. For instance, in September 2024, data published by the British Heart Foundation, a UK-based cardiovascular research charity, revealed that in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Consequently, the escalating prevalence of cardiovascular diseases is a key driver for the growth of the structural heart device market.

What Are The Principal Segment Types In The Structural Heart Devices Market?

The structural heart devicesmarket covered in this report is segmented –

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems

2) By Procedure: Replacement Procedures, Repair Procedures

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications

4) By Age Group: Pediatric, Adults

Subsegments:

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

Which Long-Term Trends Will Play A Crucial Role In The Structural Heart Devices Market?

Major companies engaged in the structural heart devices market are pursuing the development of minimally invasive treatment procedures and related devices. This effort is aimed at enhancing patient outcomes, shortening recovery times, and broadening the scope of treatment options for structural heart conditions. A prime example of such technology is the self-expanding transcatheter aortic valve implantation (TAVI) system, which is designed to precisely position and secure a replacement valve within the native aortic valve anatomy without the need for balloon inflation. Illustratively, in December 2022, Abbott Laboratories, a US-based company known for manufacturing medical devices and healthcare products, launched its advanced-generation transcatheter aortic valve implantation (TAVI) system, Navitor, in India. This system is tailored for individuals diagnosed with severe aortic stenosis who face high or extreme surgical risk, and it incorporates enhancements such as a unique design to prevent valve leakage. Navitor significantly strengthens Abbott’s structural heart transcatheter portfolio, presenting physicians and patients with less invasive treatment alternatives for various heart diseases. Notably, it stands out as the only self-expanding TAVI system featuring intra-annular leaflets and large frame cells, a design that facilitates improved access to coronary arteries for potential future interventions in coronary artery disease (CAD). Additionally, this innovative design leads to improved hemodynamics, optimizing blood flow.

Which Companies Are Contributing Significantly To The Structural Heart Devices Market Growth?

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Which Region Offers The Most Opportunity For Structural Heart Devices Market Expansion?

North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp

Browse Through More Reports Similar to the Global Structural Heart Devices Market 2025, By The Business Research Company

Structural Heart Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Hearth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearth-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Structural Heart Devices Market From 2025 To 2034?

The market encompassing devices for structural heart interventions has experienced robust expansion lately; specifically, its valuation is projected to progress from $10.41 billion in the year 2024 to $11.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.3% across this timeframe. This upward trajectory witnessed during the past period stems from several factors, including an increasing adoption of surgical methods that involve less intrusion, a high requirement for devices designed for minimally invasive structural heart procedures, continuous educational and training initiatives targeting medical practitioners, escalating overall spending on healthcare services, and a burgeoning inclination among patients toward receiving treatment options that are either non-surgical or involve the least amount of invasiveness.

Anticipation surrounds the structural heart devices sector, forecasting robust expansion ahead, with projections indicating a rise to $16.1 billion by the year 2029, achieving a cumulative yearly growth rate of 9.1%. This surge over the projection window stems from several key factors: an expanding elderly demographic, heightened public consciousness regarding cardiac wellness, the deployment of proactive diagnostic initiatives, supportive financial coverage frameworks for structural heart interventions, and the swift sanctioning of novel structural heart technologies by regulatory bodies. During this forecasted timeline, noteworthy shifts involve a greater embrace of transcatheter valve replacement techniques, continuous innovation in device creation utilizing cutting-edge substances, a mounting focus on tailoring treatments to individual patient needs, increased utilization of combined procedural approaches, and the incorporation of remote patient observation alongside telehealth services.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp

What Are The Top Growth Drivers Impacting The Structural Heart Devices Market Outlook?

The escalating occurrence of afflictions related to the heart and blood vessels is anticipated to stimulate the expansion of the structural heart device sector moving ahead. These cardiovascular ailments, encompassing issues like blocked arteries, cardiac events, and cerebrovascular incidents, are seeing a steady worldwide climb, largely attributable to inactive living patterns, substandard eating practices, increasing body mass issues, tobacco use, and an aging general populace. Structural heart technologies serve to manage these conditions by mending or substituting compromised cardiac valves, rectifying inherent structural anomalies, and ultimately enhancing cardiac performance and results for those afflicted. To illustrate this burden, data disclosed in September 2024 by the British Heart Foundation, a UK research foundation focused on heart health, indicated that roughly 7.6 million individuals across the United Kingdom suffer from heart and circulatory illnesses, with the numbers broken down into roughly 4 million men and 3.6 million women battling these problems. These maladies are accountable for an estimated twenty-seven percent of all fatalities within the United Kingdom, amounting to over 170,000 lost lives annually, or approximately 480 fatalities every twenty-four hours, which translates to one life lost in every three-minute interval. Consequently, the increasing incidence of cardiovascular diseases is serving as a major impetus for the structural heart device market’s upward trajectory.

What Are The Major Segment Categories Driving The Structural Heart Devices Market Growth?

The structural heart devicesmarket covered in this report is segmented –

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems

2) By Procedure: Replacement Procedures, Repair Procedures

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications

4) By Age Group: Pediatric, Adults

Subsegments:

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

Which Market Trends Are Creating New Opportunities In The Structural Heart Devices Industry?

In the realm of the structural heart devices market, leading corporations are actively innovating by creating less invasive surgical techniques and apparatuses aimed at boosting patient recovery speeds, improving results for those treated, and broadening the available interventions for various structural heart ailments. A notable technology in this space is the self-expanding transcatheter aortic valve implantation (TAVI) system, engineered to position and fix a replacement valve within the existing aortic valve structure without the necessity of balloon expansion. To illustrate this progress, in December of 2022, Abbott Laboratories, an American entity producing medical implements and healthcare supplies, rolled out its newest generation TAVI system, branded Navitor, within the Indian market; this system is specifically designed for high or prohibitive surgical risk patients afflicted with severe aortic stenosis and incorporates novel attributes like a distinctive configuration intended to mitigate valve regurgitation, thereby bolstering Abbott’s collection of less invasive transcatheter treatments for cardiac pathologies, granting both medical practitioners and patients more choice. What distinguishes Navitor is its unique status as the only self-expanding TAVI device featuring intra-annular leaflets alongside generously sized frame cells, which significantly eases subsequent access to coronary arteries for potential future procedures related to coronary artery disease, furthermore, this modernized structure contributes to superior hemodynamics, ensuring optimal blood circulation.

Which Industry Leaders Are Driving Innovation Across The Structural Heart Devices Market?

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Structural Heart Devices Market?

North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Structural Heart Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp

Browse Through More Reports Similar to the Global Structural Heart Devices Market 2025, By The Business Research Company

Structural Heart Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Hearth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearth-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Structural Heart Devices Market In 2029?

In recent times, there has been robust growth in the structural heart devices market size. This market is projected to expand from $10.41 billion in 2024 to $11.37 billion in 2025, at a compound annual growth rate (CAGR) of 9.3%. Factors leading to growth during the historic period included the transition towards less invasive surgical methods, the rising demand for minimally invasive structural heart devices, continuous education and training initiatives for healthcare professionals, the escalating expenditure on healthcare, and the increasing preference among patients for non-surgical or minimally invasive treatment alternatives.

The market size of structural heart devices is predicted to experience significant expansion in the coming years. The anticipated growth rate is predicted to reach $16.1 billion in 2029, with a compound annual growth rate (CAGR) of 9.1%. The projected growth for the period is ascribed to factors such as the rise in the aging population, heightened cognizance on heart health, initiation of screening programs, advantageous reimbursement policies for structural heart procedures, as well as prompt regulatory endorsements for novel structural heart devices. Notable trends to be seen in the prediction period include the rise in the adoption of transcatheter valve replacement, continuous development of pioneering devices using top-tier materials, an escalating focus on customized treatment methodologies, the growing acceptance of hybrid procedures, and the integration of remote monitoring coupled with telehealth solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp

What Are the Core Growth Drivers Propelling the Structural Heart Devices Market Forward?

The growth of the structural heart device market is anticipated to be driven by the increasing incidence rate of cardiovascular diseases. Cardiovascular diseases (CVDs), a collection of disorders impacting the heart and blood vessels, encompass diseases like coronary artery disease, heart attacks, and strokes. Globally, due to sedentary lifestyles, unhealthy eating habits, growing obesity rates, smoking, and aging populations, there has been a consistent rise in cases of cardiovascular diseases, including heart disease and stroke. Structural heart devices, which repair or replace damaged heart valves, correct structural defects and enhance heart function and patient outcomes, are used in the treatment of cardiovascular diseases. For example, data published by the British Heart Foundation, a cardiovascular research charity based in the UK, revealed that around 7.6 million people in the UK are living with heart and circulatory diseases as of September 2024. This includes about 4 million men and roughly 3.6 million women. This accounts for around 27% of all deaths in the UK, equal to over 170,000 deaths per year, or about 480 deaths daily. This suggests one death every three minutes. Hence, the rising incidence of cardiovascular diseases is fuelling the expansion of the structural heart device market.

What Segment Types Define the Structural Heart Devices Market Structure?

The structural heart devicesmarket covered in this report is segmented –

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems

2) By Procedure: Replacement Procedures, Repair Procedures

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications

4) By Age Group: Pediatric, Adults

Subsegments:

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Structural Heart Devices Market?

North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theStructural Heart Devices Industry Evolution?

Major firms in the structural heart devices market are innovating to create minimally invasive procedures and devices, with the goal of improving patient results, decreasing recovery periods, and broadening the range of treatment options for structural heart diseases. A self-expanding transcatheter aortic valve implantation (TAVI) system is one such device, specifically designed to position and secure the replacement valve within the original aortic valve anatomy without the need for balloon inflation. For example, Abbott Laboratories, a manufacturer of medical devices and healthcare products based in the US, introduced the latest-generation TAVI system, Navitor, in India in December 2022. This system is custom-made for individuals at high or extreme surgical risk due to severe aortic stenosis hinging on innovative features like a distinctive design aimed at preventing valve leakage. Navitor bolsters Abbott’s transcatheter portfolio in the structural heart space, providing more minimally invasive solutions to both physicians and patients tackling heart diseases. Uniquely, it is the only self-expanding TAVI system equipped with intra-annular leaflets and large frame cells, which enables easier access to coronary arteries for potential subsequent interventions in coronary artery disease (CAD). Furthermore, this new design aids in enhancing hemodynamics for optimal blood flow.

View the full report here:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

What Is the Definition of the Structural Heart Devices Market?

Structural heart devices are specialized medical implants or tools designed for the treatment of various structural defects or abnormalities affecting the heart. It is used to repair or replace damaged heart structures, such as valves or septa, restoring normal heart functions and improving patient outcomes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15677

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Are the Projected Market Size and Growth Rates for the Structural Heart Devices Market From 2025 To 2029?#_x000D_

In recent years, the structural heart devices market has seen substantial growth. It is forecasted to increase from $10.41 billion in 2024 to $11.44 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.9%. The growth observed in the past years can be associated with the trend towards less invasive surgical techniques, the rising demand for minimally invasive structural heart devices, continuous education and training programs for healthcare professionals, the increasing expenditure on healthcare, and the preference of patients towards non-surgical or minimally invasive treatments._x000D_

_x000D_

#What Is the Projected Market Size of the Structural Heart Devices Market?#_x000D_

Expectations are high for significant expansion in the structural heart devices market over the coming years. The market is forecasted to reach $16.48 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.6%. This projected growth during the forecast period is due to factors such as the rise in the aging population, increased awareness regarding heart health, the establishment of screening programs, favorable reimbursement schemes for structural heart operations, and prompt regulatory approvals for novel structural heart devices. Key trends during this period include the growing adoption of transcatheter valve replacement, continuous advancements in the development of innovative devices using superior materials, a rising focus on personalized treatment strategies, the increasing adoption of hybrid procedures, and the inclusion of remote monitoring and telehealth solutions._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp_x000D_

_x000D_

#Who are the Major Competitors in the Structural Heart Devices Market Outlook?#_x000D_

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc._x000D_

_x000D_

#What Is Fueling Growth in the Structural Heart Devices Market?#_x000D_

The increasing instances of cardiovascular diseases are anticipated to stimulate the expansion of the structural heart device market. Cardiovascular diseases (CVDs) include a series of disorders that affect the heart and blood vessels, including the likes of coronary artery disease, heart attacks, and strokes. Owing to factors such as sedentary lifestyles, unhealthy diets, climbing obesity stats, smoking, and aging populations, the worldwide rate of cardiovascular diseases, including strokes and heart diseases, has been progressively on the rise. Structural heart devices work to treat cardiovascular diseases by rectifying or replacing impaired heart valves, amending structural defects, and enhancing heart function and patient outcomes. For example, data from the British Heart Foundation in September 2024 disclosed that in the UK, about 7.6 million people suffer from heart and circulatory diseases, including about 4 million men and 3.6 million women. These diseases account for roughly 27% of all UK’s deaths, culminating in over 170,000 deaths per year or approximately 480 deaths per day, indicating one death every three minutes. As a result, the escalating occurrences of cardiovascular diseases are fueling the growth of the structural heart device market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp_x000D_

_x000D_

#Which Structural Heart Devices Market Segments Are Growing the Fastest?#_x000D_

The structural heart devices market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems_x000D_

2) By Procedure: Replacement Procedures, Repair Procedures_x000D_

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications_x000D_

4) By Age Group: Pediatric, Adults_x000D_

_x000D_

Subsegments:_x000D_

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings_x000D_

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings_x000D_

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders_x000D_

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems_x000D_

_x000D_

#Which Industry Trends Are Shaping the Future of the Structural Heart Devices Market?#_x000D_

Significant players in the structural heart devices market, such as Abbott Laboratories, are innovating minimally invasive procedures and equipment aimed at improving patient results, shortening healing time, and introducing more options to treat structural heart diseases. One such innovation is a self-expanding transcatheter aortic valve implantation (TAVI) system. This device is engineered to bring into service and anchor the substitute valve within the original aortic valve anatomy without the necessity for balloon enlargement. In December 2022, Abbott Laboratories, a healthcare product manufacturer from the United States, released its latest-generation TAVI system, Navitor, in India. This system is designed specifically for individuals at high or extreme surgical risk due to severe aortic stenosis and includes advanced features like a unique structure to inhibit valve leakage. With its superior design to reduce valve leakage and enhance Abbott’s structural heart catheter portfolio, Navitor provides physicians and patients with more choices for minimally invasive therapies for heart conditions. Notably, it is the only self-expanding TAVI system with intra-annular leaflets and large frame cells, which provides better access to coronary arteries for possible future CAD interventions. Additionally, the new design positively impacts hemodynamics by optimizing blood flow._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report_x000D_

_x000D_

#Which Countries Are Leading the Structural Heart Devices Market?#_x000D_

North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15677_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the structural heart devices market, and how is it changing globally?_x000D_

2. Who are the major companies in the structural heart devices market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the structural heart devices market right now?_x000D_

4. Which products or customer segments are growing the most in the structural heart devices market?_x000D_

5. What factors are helping or slowing down the growth of the structural heart devices market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the structural heart devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Structural Heart Devices Market In 2029?

The market size for structural heart devices has seen a robust expansion in the past few years. The market value is set to rise from $10.41 billion in 2024 to $11.44 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. The historic growth owes to the transition towards more non-invasive surgical methods, the increasing demand for minimally invasive structural heart devices, continuous training and education initiatives for healthcare workers, escalating health care expenses, and a rise in the preference of patients for non-surgical or minimally invasive therapeutic alternatives.

As per predictions, the structural heart devices market is on the path to considerable expansion in the coming years. The size of the market is forecasted to reach $16.48 billion in 2029 with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to growth during this forecast period include a rise in the elderly population, heightened awareness about cardiac health, execution of screening programs, supportive repayment strategies for structural heart procedures, and prompt regulatory greenlights for novel structural heart devices. Some predicted trends during this time span encompass increasing traction for transcatheter valve replacements, continuous advancement of innovative devices using cutting-edge materials, an amplified focus on customized treatment plans, escalating adoption of hybrid procedures, along with incorporation of remote tracking and telehealth facilities.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp

Which Primay Drivers Are Accelerating Growth in the Structural Heart Devices Market?

The escalating incidence of cardiovascular diseases is anticipated to fuel the expansion of the structural heart device market in the future. Cardiovascular diseases are a collection of maladies impacting the heart and blood vessels, encompassing conditions like coronary artery disease, heart attacks, and strokes. Due to inactive lifestyles, unhealthy eating habits, increasing obesity levels, smoking, and aging populations, the number of cardiovascular disease cases, including strokes and heart illnesses, has been progressively rising worldwide. Structural heart devices help treat cardiovascular diseases by rectifying or replacing impaired heart valves, fixing structural abnormalities, and enhancing heart function and patient results. For instance, as per the British Heart Foundation’s data published in September 2024, around 7.6 million people are stricken by heart and circulatory diseases in the UK, including approximately 4 million males and 3.6 million females. These diseases account for about 27% of all UK deaths, resulting in over 170,000 deaths yearly or nearly 480 deaths each day, equivalent to one death every three minutes. Therefore, the escalating incidence of cardiovascular diseases is pushing the expansion of the structural heart device market.

What Segment Types Define the Structural Heart Devices Market Structure?

The structural heart devices market covered in this report is segmented –

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems

2) By Procedure: Replacement Procedures, Repair Procedures

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications

4) By Age Group: Pediatric, Adults

Subsegments:

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp

Which Regions Are Key Players in the Growth of the Structural Heart Devices Market?

North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Structural Heart Devices Market?

Prominent players in the structural heart devices market are innovating minimally invasive techniques and devices that aim to boost patient results, shorten recovery durations, and provide a broader range of solutions for structural heart issues. A prime example is the self-expanding transcatheter aortic valve implantation (TAVI) system, which is engineered to unfold and fix the replacement valve within the existing aortic valve structure, without the necessity of balloon inflation. In a significant development in December 2022, Abbott Laboratories, a healthcare product and medical device manufacturer based in the US, introduced in India its latest-generation TAVI system, Navitor. It caters to the needs of those with serious aortic stenosis and categorized in high or extreme surgical risk, and it incorporates enhancements such as an exceptional design for valve leakage prevention. Navitor not only boosts Abbott’s transcatheter offerings in the structural heart space, but it also provides doctors and patients a less invasive alternative for heart condition treatments. It is the sole self-expanding TAVI system with intra-annular leaflets and sizeable frame cells, providing better accessibility for possible future interventions in coronary artery disease (CAD). Its design also improves hemodynamics, which facilitates optimal blood flow.

View the full report here:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

What Is the Definition of the Structural Heart Devices Market?

Structural heart devices are specialized medical implants or tools designed for the treatment of various structural defects or abnormalities affecting the heart. It is used to repair or replace damaged heart structures, such as valves or septa, restoring normal heart functions and improving patient outcomes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15677

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model